Enterprise Therapeutics
Falmer
About Enterprise Therapeutics
Enterprise Therapeutics is a drug discovery company dedicated to the research and development of novel therapies for the treatment of respiratory diseases. In diseases such as cystic fibrosis, asthma and COPD the lungs become congested with mucus leading to difficulty in breathing. New disease modifying therapies that target the underlying mechanisms of mucus congestion will reduce the frequency of lung infections and improve patient quality of life.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $10K – $50K
- Total funding: $93.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Jan 2024)
- Website: enterprisetherapeutics.com
- Phone: 44 7765 220 733
Industries & Categories
Health Care, Health Diagnostics, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/enterprise-therapeutics-109038 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.